Gilead Sciences Derivative Liabilities Offset increased by 314.3% to $29.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 314.3%, from $7.00M to $29.00M. Over 4 years (FY 2020 to FY 2024), Derivative Liabilities Offset shows a downward trend with a -29.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher offsets indicate better risk mitigation and lower net cash settlement requirements for derivative contracts.
This represents the gross derivative liabilities that are mitigated by the right to reclaim cash or collateral from coun...
Standard disclosure for major financial institutions engaged in market-making and hedging activities.
derivative_liabilities_offset| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.00M | $7.00M | $4.00M | $9.00M | $3.00M | $2.00M | $36.00M | $24.00M | $19.00M | $8.00M | $7.00M | $8.00M | $2.00M | $7.00M | $3.00M | $25.00M | $7.00M | $29.00M |
| QoQ Change | — | -63.2% | -42.9% | +125.0% | -66.7% | -33.3% | >999% | -33.3% | -20.8% | -57.9% | -12.5% | +14.3% | -75.0% | +250.0% | -57.1% | +733.3% | -72.0% | +314.3% |
| YoY Change | — | — | — | — | -84.2% | -71.4% | +800.0% | +166.7% | +533.3% | +300.0% | -80.6% | -66.7% | -89.5% | -12.5% | -57.1% | +212.5% | +250.0% | +314.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.